Literature DB >> 24478542

"P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences".

Emad F Eskander1, Ahmed A Abd-Rabou1, Shaymaa M M Yahya1, Ashraf El Sherbini2, Mervat S Mohamed3, Olfat G Shaker4.   

Abstract

Viral infection with hepatitis C virus (HCV) has a high propensity in becoming chronic and it is the major cause of hepatocellular carcinoma (HCC) worldwide. This review was basically established to illustrate the putative role of the P53 gene Arg72Pro polymorphism on various cancer models and viral infections, focusing on HCV and HCC incidences. Authors studied the 72 G/C single base substitution of P53 gene at codon 72 using various polymorphic techniques. Intriguingly, authors investigated that the P53 codon 72 plays a crucial role as risk factor in several cancer models. Others found that there is no association between codon 72 genotypes and HCV disease severity or liver cancer. Moreover, the lack of a significant relationship between this polymorphism and risk of HCC shows that it does not predispose towards hepatocarcinogenesis and the frequent loss of the proline allele in HCV-associated carcinogenesis of the liver plays some critical role in hepatocarcinogenesis. Amazingly, there is a significant correlation between male homozygotes for P53 72Pro with HCV type 1b infection. However, there was no significant difference between the P53 polymorphism and HCV genotypes 2a and 2b. It was concluded that the P53 gene polymorphism at codon 72 has been investigated as potential risk factor in several cancer models and HCV infections.

Entities:  

Keywords:  Hepatitis C; Hepatocarcinoma; P53 codon 72

Year:  2013        PMID: 24478542      PMCID: PMC3903935          DOI: 10.1007/s12291-013-0317-0

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  41 in total

1.  Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.

Authors:  K Yamaguchi; K Sugano; N Fukayama; Y Nakashima; K Saotome; T Yokoyama; T Yokota; H Ohkura
Journal:  Am J Gastroenterol       Date:  1997-02       Impact factor: 10.864

2.  Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

Authors:  A Storey; M Thomas; A Kalita; C Harwood; D Gardiol; F Mantovani; J Breuer; I M Leigh; G Matlashewski; L Banks
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

3.  p53 Codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours.

Authors:  G Sourvinos; E Rizos; D A Spandidos
Journal:  Oral Oncol       Date:  2001-10       Impact factor: 5.337

4.  Mutation of the p53 tumor suppressor gene in transitional cell carcinoma of the urinary tract in Taiwan.

Authors:  Hung-Yu Lin; Chun-Hsiung Huang; Wen-Jen Wu; Yii-Her Chou; Pao-Luo Fan; For-Wey Lung
Journal:  Kaohsiung J Med Sci       Date:  2005-02       Impact factor: 2.744

5.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

Review 6.  Relationship of p53 to the control of apoptotic cell death.

Authors:  M Oren
Journal:  Semin Cancer Biol       Date:  1994-06       Impact factor: 15.707

7.  P53 germ line haplotypes associated with increased risk for colorectal cancer.

Authors:  A Själander; R Birgander; L Athlin; R Stenling; J Rutegård; L Beckman; G Beckman
Journal:  Carcinogenesis       Date:  1995-07       Impact factor: 4.944

8.  p53 polymorphisms and haplotypes in breast cancer.

Authors:  A Själander; R Birgander; G Hallmans; S Cajander; P Lenner; L Athlin; G Beckman; L Beckman
Journal:  Carcinogenesis       Date:  1996-06       Impact factor: 4.944

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

10.  [Mutations of p53 gene in 41 cases of human brain gliomas].

Authors:  Wen Cui; Xia Kong; Hui-Ling Cao; Xu Wang; Ji-Fa Gao; Ren-Liang Wu; Xue-Chun Wang
Journal:  Ai Zheng       Date:  2008-01
View more
  1 in total

1.  Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment.

Authors:  Chiung-Chyi Shen; Wen-Yu Cheng; Chung-Hsin Lee; Xue-Jun Dai; Ming-Tsang Chiao; Yea-Jiuen Liang; Wan-Yu Hsieh; Tsuo-Fei Mao; Guo-Shi Lin; Shou-Ren Chen; Bai-Shuan Liu; Jun-Peng Chen
Journal:  BMC Cancer       Date:  2020-07-29       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.